跳至主要内容
临床试验/JPRN-jRCT1030220111
JPRN-jRCT1030220111招募中未知

Multicenter prospective observational study to identify plasm beta cell-specific peptides

Miyatsuka Takeshi0 个研究点目标入组 300 人开始时间: 2022年6月4日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • More than 18 years old patients with a diagnosis of type 1 diabetes and type 1 diabetes caused by immune checkpoint inhibitors from the date of approval by the hospital director to March 31, 2025, have been started treatment at the Department of Endocrinology and Metabolism, Kitasato University Hospital or the Department of Endocrinology and Metabolism, Kitasato University Medical Center, understand the purpose of this study and are given consent. More than 18 years old normal glucose-tolerant subjects (volunteers) understand the purpose of the study and are given their consent. Volunteers will be recruited by posting posters on the bulletin board in the School of Medicine.

排除标准

  • 未提供

研究者

发起方
Miyatsuka Takeshi

相似试验